Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Goadsby, Peter J, Wietecha, Linda A, Dennehy, Ellen B, Kuca, Bernice, Case, Michael G, Aurora, Sheena K, Gaul, Charly
Published in Brain (London, England : 1878) (01.07.2019)
Published in Brain (London, England : 1878) (01.07.2019)
Get full text
Journal Article
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
Ford, Janet H., Kurth, Tobias, Starling, Amaal J., Ayer, David W., Wietecha, Linda A., Port, Martha D., Rettiganti, Mallikarjuna, Ruff, Dustin D.
Published in Headache (01.11.2020)
Published in Headache (01.11.2020)
Get full text
Journal Article
Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine
Bangs, Mark E, Wietecha, Linda A, Wang, Shufang, Buchanan, Andrew S, Kelsey, Douglas K
Published in Journal of child and adolescent psychopharmacology (01.10.2014)
Published in Journal of child and adolescent psychopharmacology (01.10.2014)
Get full text
Journal Article
Reading outcomes of children and adolescents with attention-deficit/hyperactivity disorder and dyslexia following atomoxetine treatment
Shaywitz, Bennett A, Williams, David W, Fox, Bethany K, Wietecha, Linda A
Published in Journal of child and adolescent psychopharmacology (01.10.2014)
Published in Journal of child and adolescent psychopharmacology (01.10.2014)
Get full text
Journal Article
Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials
Wietecha, Linda A., Clemow, David B., Buchanan, Andrew S., Young, Joel L., Sarkis, Elias H., Findling, Robert L.
Published in CNS neuroscience & therapeutics (01.07.2016)
Published in CNS neuroscience & therapeutics (01.07.2016)
Get full text
Journal Article
Differential response profiles in children and adolescents with attention-deficit/hyperactivity disorder: treatment with atomoxetine
Wietecha, Linda A, Wang, Shufang, Saylor, Keith E, Day, Kathleen A, Wu, Sheng Hu, Kelsey, Doug
Published in Clinical pediatrics (01.02.2015)
Published in Clinical pediatrics (01.02.2015)
Get more information
Journal Article
Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States
Meyers, Juliana, Classi, Peter, Wietecha, Linda, Candrilli, Sean
Published in Child and adolescent psychiatry and mental health (14.12.2010)
Published in Child and adolescent psychiatry and mental health (14.12.2010)
Get full text
Journal Article
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia
Sumner, Calvin R, Gathercole, Susan, Greenbaum, Michael, Rubin, Richard, Williams, David, Hollandbeck, Millie, Wietecha, Linda
Published in Child and adolescent psychiatry and mental health (15.12.2009)
Published in Child and adolescent psychiatry and mental health (15.12.2009)
Get full text
Journal Article
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Kuca, Bernice, Silberstein, Stephen D, Wietecha, Linda, Berg, Paul H, Dozier, Gregory, Lipton, Richard B
Published in Neurology (11.12.2018)
Published in Neurology (11.12.2018)
Get more information
Journal Article
Does “wearing off” of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials
Ailani, Jessica, Kuruppu, Dulanji K., Rettiganti, Mallikarjuna, Oakes, Tina, Schroeder, Krista, Wietecha, Linda, Port, Martha, Blumenfeld, Andrew M.
Published in Headache (01.02.2022)
Published in Headache (01.02.2022)
Get full text
Journal Article
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist
Kudrow, David, Nguyen, Linda, Semler, Jack, Stroud, Chad, Samaan, Karen, Hoban, Deirdre B., Wietecha, Linda, Hsu, Hai‐An, Pearlman, Eric
Published in Headache (01.10.2022)
Published in Headache (01.10.2022)
Get full text
Journal Article
Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms
McBurnett, Keith, Clemow, David, Williams, David, Villodas, Miguel, Wietecha, Linda, Barkley, Russell
Published in Journal of child and adolescent psychopharmacology (01.02.2017)
Published in Journal of child and adolescent psychopharmacology (01.02.2017)
Get full text
Journal Article
Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial
Shaywitz, Sally, Shaywitz, Bennett, Wietecha, Linda, Wigal, Sharon, McBurnett, Keith, Williams, David, Kronenberger, William G, Hooper, Stephen R
Published in Journal of child and adolescent psychopharmacology (01.02.2017)
Published in Journal of child and adolescent psychopharmacology (01.02.2017)
Get full text
Journal Article
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial
Wietecha, Linda, Williams, David, Shaywitz, Sally, Shaywitz, Bennett, Hooper, Stephen R, Wigal, Sharon B, Dunn, David, McBurnett, Keith
Published in Journal of child and adolescent psychopharmacology (01.11.2013)
Published in Journal of child and adolescent psychopharmacology (01.11.2013)
Get full text
Journal Article
Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial
Young, Joel L, Sarkis, Elias, Qiao, Meihua, Wietecha, Linda
Published in Clinical neuropharmacology (01.03.2011)
Published in Clinical neuropharmacology (01.03.2011)
Get more information
Journal Article
Évolution de la productivité au travail/l’impact des migraines entre les crises : résultats d’une étude clinique randomisée, en double aveugle et contrôlée vs placebo sur le galcanézumab chez des adultes souffrant de migraine difficile à traiter (CONQUER)
Garcia-Azorin, David, Ford, Janet, Buse, Dawn C., Hand, Austin, Wietecha, Linda, Detke, Holland C., Fawcett, Katie
Published in Revue neurologique (01.04.2021)
Published in Revue neurologique (01.04.2021)
Get full text
Journal Article
Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning
Wietecha, Linda, Young, Joel, Ruff, Dustin, Dunn, David, Findling, Robert L, Saylor, Keith
Published in Clinical neuropharmacology (01.05.2012)
Published in Clinical neuropharmacology (01.05.2012)
Get more information
Journal Article